Gas6 Promotes Oligodendrogenesis and Myelination in the Adult Central Nervous System and After Lysolecithin-Induced Demyelination

ASN Neuro

Volumn 8, Issue 5, 2016, Pages

  Goudarzi, Salman ^a   Rivera, Andrea ^a   Butt, Arthur M ^a   Hafizi, Sassan ^a  

^a UNIVERSITY OF PORTSMOUTH   (United Kingdom)

Author keywords

multiple sclerosis; myelin; oligodendrocyte; receptor tyrosine kinase; TAM receptors; Tyro3

Indexed keywords

GELATINASE B; GREEN FLUORESCENT PROTEIN; GROWTH ARREST SPECIFIC PROTEIN 6; LYSOPHOSPHATIDYLCHOLINE; MYELIN BASIC PROTEIN; STAT3 PROTEIN; TOSYLARGININE METHYL ESTER; AXL RECEPTOR TYROSINE KINASE; CDC40 PROTEIN, HUMAN; CELL CYCLE PROTEIN; NERVE PROTEIN; ONCOPROTEIN; PROTEIN TYROSINE KINASE; RNA SPLICING FACTOR; SOX10 PROTEIN, MOUSE; TRANSCRIPTION FACTOR SOX;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CELL REGENERATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DEMYELINATION; DOWN REGULATION; DRUG INDUCED DISEASE; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LYSOLECITHIN INDUCED DEMYELINATION; MOUSE; MULTIPLE SCLEROSIS; MYELINATION; NONHUMAN; OLIGODENDROGENESIS; OLIGODENDROGLIA; ORGANELLE BIOGENESIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REMYELINIZATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CEREBELLUM; CHEMICALLY INDUCED; CYTOLOGY; DEMYELINATING DISEASE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; GLIA; METABOLISM; NEWBORN; OPTIC NERVE; PHYSIOLOGY; REGENERATION; TRANSGENIC MOUSE;

ANIMALS; ANIMALS, NEWBORN; CELL CYCLE PROTEINS; CEREBELLUM; DEMYELINATING AUTOIMMUNE DISEASES, CNS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; LYSOPHOSPHATIDYLCHOLINES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYELIN BASIC PROTEIN; NERVE TISSUE PROTEINS; NEUROGLIA; OLIGODENDROGLIA; OPTIC NERVE; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; REGENERATION; RNA SPLICING FACTORS; SIGNAL TRANSDUCTION; SOXE TRANSCRIPTION FACTORS;

EID: 85009247882     PISSN: None     EISSN: 17590914     Source Type: Journal    
DOI: 10.1177/1759091416668430     Document Type: Article

References (57)

1. Alvarez J. I., Cayrol R., Prat A., (2011) Disruption of central nervous system barriers in multiple sclerosis. Biochimica et Biophysica Acta 1812: 252–264.
2. Aung L. L., Mouradian M. M., Dhib-Jalbut S., Balashov K. E., (2015) MMP-9 expression is increased in B lymphocytes during multiple sclerosis exacerbation and is regulated by microRNA-320a. Journal of Neuroimmunology 278: 185–189.
3. Azim K., Butt A. M., (2011) GSK3beta negatively regulates oligodendrocyte differentiation and myelination in vivo. Glia 59: 540–553.
4. Barcena C., Stefanovic M., Tutusaus A., Joannas L., Menendez A., Garcia-Ruiz C., Morales A., (2015) Gas6/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation. Journal of Hepatology 63: 670–678.
5. Beckerman S. R., Jimenez J. E., Shi Y., Al-Ali H., Bixby J. L., Lemmon V. P., (2015) Phenotypic assays to identify agents that induce reactive gliosis: A counter-screen to prioritize compounds for preclinical animal studies. Assay and Drug Development Technologies 13: 377–388.
6. Binder M. D., Xiao J., Kemper D., Ma G. Z., Murray S. S., Kilpatrick T. J., (2011) Gas6 increases myelination by oligodendrocytes and its deficiency delays recovery following cuprizone-induced demyelination. PLoS One 6: e17727.
7. Birgbauer E., Rao T. S., Webb M., (2004) Lysolecithin induces demyelination in vitro in a cerebellar slice culture system. Journal of Neuroscience Research 78: 157–166.
8. Butt A. M., Pugh M., Hubbard P., James G., (2004) Functions of optic nerve glia: Axoglial signalling in physiology and pathology. Eye (Lond) 18: 1110–1121.
9. Chen J., Carey K., Godowski P. J., (1997) Identification of Gas6 as a ligand for Mer, a neural cell adhesion molecule related receptor tyrosine kinase implicated in cellular transformation. Oncogene 14: 2033–2039.
10. De Simoni A., Yu L. M., (2006) Preparation of organotypic hippocampal slice cultures: Interface method. Nature Protocols 1: 1439–1445.
11. Emery B., (2010) Regulation of oligodendrocyte differentiation and myelination. Science 330: 779–782.
12. Ferguson S. D., Srinivasan V. M., Heimberger A. B., (2015) The role of STAT3 in tumor-mediated immune suppression. Journal of Neuro-oncology 123: 385–394.
13. Fourgeaud L., Traves P. G., Tufail Y., Leal-Bailey H., Lew E. D., Burrola P. G., Lemke G., (2016) TAM receptors regulate multiple features of microglial physiology. Nature 532: 240–244.
14. Franklin R. J. M., (2002) Why does remyelination fail in multiple sclerosis? Nature Reviews 3: 9.
15. Fukada T., Hibi M., Yamanaka Y., Takahashi-Tezuka M., Fujitani Y., Yamaguchi T., Hirano T., (1996) Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: Involvement of STAT3 in anti-apoptosis. Immunity 5: 449–460.
16. Gonzalez-Pereza O., Alvarez-Buyllab A., (2011) Oligodendrogenesis in the subventricular zone and the role of epidermal growth factor. Brain Research Reviews 67: 9.
17. Goudarzi S., Smith L. J., Schutz S., Hafizi S., (2013) Interaction of DISC1 with the PTB domain of Tensin2. Cellular and Molecular Life Sciences: CMLS 70: 1663–1672.
18. Hafizi S., Dahlbäck B., (2006a) Gas6 and protein S. Vitamin K-dependent ligands for the Axl receptor tyrosine kinase subfamily. FEBS Journal 273: 5231–5244.
19. Hafizi S., Dahlbäck B., (2006b) Signalling and functional diversity within the Axl subfamily of receptor tyrosine kinases. Cytokine Growth Factor Reviews 17: 295–304.
20. He X., Shen L., Bjartell A., Dahlback B., (1995) The gene encoding vitamin K-dependent anticoagulant protein S is expressed in multiple rabbit organs as demonstrated by northern blotting, in situ hybridization, and immunohistochemistry. The Journal of Histochemistry and Cytochemistry: Official Journal of the Histochemistry Society 43: 85–96.
21. Hesp Z. C., Goldstein E. A., Miranda C. J., Kaspar B. K., McTigue D. M., (2015) Chronic oligodendrogenesis and remyelination after spinal cord injury in mice and rats. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 35: 1274–1290.
22. Hoehn H. J., Kress Y., Sohn A., Brosnan C. F., Bourdon S., Shafit-Zagardo B., (2008) Axl-/- mice have delayed recovery and prolonged axonal damage following cuprizone toxicity. Brain Research 1240: 1–11.
23. Korshunov V. A., (2012) Axl-dependent signalling: A clinical update. Clinical Science 122: 361–368.
24. Kuhlmann T., Miron V., Cui Q., Wegner C., Antel J., Bruck W., (2008) Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain: A Journal of Neurology 131: 1749–1758.
25. Lemke G., Lu Q., (2003) Macrophage regulation by Tyro 3 family receptors. Current Opinion in Immunology 15: 31–36.
26. Li R., Chen J., Hammonds G., Phillips H., Armanini M., Wood P., Mather J. P., (1996) Identification of Gas6 as a growth factor for human Schwann cells. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 16: 2012–2019.
27. Liu Y., Holdbrooks A. T., De Sarno P., Rowse A. L., Yanagisawa L. L., McFarland B. C., Qin H., (2014) Therapeutic efficacy of suppressing the Jak/STAT pathway in multiple models of experimental autoimmune encephalomyelitis. Journal of Immunology 192: 59–72.
28. Livak K. J., Schmittgen T. D., (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402–408.
29. Lu Q., Lemke G., (2001) Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science 293: 306–311.
30. Mi S., Lee X., Hu Y., Ji B., Shao Z., Yang W., Pepinsky R. B., (2011) Death receptor 6 negatively regulates oligodendrocyte survival, maturation and myelination. Nature Medicine 17: 816–821.
31. Miyamoto Y., Torii T., Takada S., Ohno N., Saitoh Y., Nakamura K., Yamauchi J., (2015) Involvement of the Tyro3 receptor and its intracellular partner Fyn signaling in Schwann cell myelination. Molecular Biology of the Cell 26: 3489–3503.
32. Nobuta H., Ghiani C. A., Paez P. M., Spreuer V., Dong H., Korsak R. A., Waschek J. A., (2012) STAT3-mediated astrogliosis protects myelin development in neonatal brain injury. Annals of Neurology 72: 750–765.
33. O’Bryan J. P., Fridell Y. W., Koski R., Varnum B., Liu E. T., (1995) The transforming receptor tyrosine kinase, Axl, is post-translationally regulated by proteolytic cleavage. The Journal of Biological Chemistry 270: 551–557.
34. Owshalimpur D., Kelley M. J., (1999) Genomic structure of the EPHA1 receptor tyrosine kinase gene. Molecular and Cellular Probes 13: 169–173.
35. Pierce A. M., Keating A. K., (2014) TAM receptor tyrosine kinases: Expression, disease and oncogenesis in the central nervous system. Brain Research 1542: 206–220.
36. Prieto A. L., O’Dell S., Varnum B., Lai C., (2007) Localization and signaling of the receptor protein tyrosine kinase Tyro3 in cortical and hippocampal neurons. Neuroscience 150: 319–334.
37. Prieto A. L., Weber J. L., Lai C., (2000) Expression of the receptor protein-tyrosine kinases Tyro-3, Axl, and mer in the developing rat central nervous system. The Journal of Comparative Neurology 425: 295–314.
38. Prieto A. L., Weber J. L., Tracy S., Heeb M. J., Lai C., (1999) Gas6, a ligand for the receptor protein-tyrosine kinase Tyro-3, is widely expressed in the central nervous system1. Brain Research 816: 646–661.
39. Qi Q. R., Yang Z. M., (2014) Regulation and function of signal transducer and activator of transcription 3. World Journal of Biological Chemistry 5: 231–239.
40. Ravindran J., Agrawal M., Gupta N., Rao P. V., (2011) Alteration of blood brain barrier permeability by T-2 toxin: Role of MMP-9 and inflammatory cytokines. Toxicology 280: 44–52.
41. Saxena A., Martin-Blondel G., Mars L. T., RSL. (2011) Role of CD8 T cell subsets in the pathogenesis of multiple sclerosis. FEBS Letters 585: 6.
42. Scheller A., Kirchhoff F., (2009) Astrocyte: Identification Methods. In: Squire L. R., (ed.) Encyclopedia of neuroscience, Oxford, England: Academic Press, pp. 573–577.
43. Schmittgen T. D., Livak K. J., (2008) Analyzing real-time PCR data by the comparative C(T) method. Nature Protocols 3: 1101–1108.
44. Schneider C. A., Rasband W. S., Eliceiri K. W., (2012) NIH Image to ImageJ: 25 years of image analysis. Nature Methods 9: 671–675.
45. Schulz N. T., Paulhiac C. I., Lee L., Zhou R., (1995) Isolation and expression analysis of tyro3, a murine growth factor receptor tyrosine kinase preferentially expressed in adult brain. Molecular Brain Research 28: 273–280.
46. Seo J. H., Miyamoto N., Hayakawa K., Pham L. D., Maki T., Ayata C., Arai K., (2013) Oligodendrocyte precursors induce early blood-brain barrier opening after white matter injury. The Journal of Clinical Investigation 123: 782–786.
47. Shankar S. L., O’Guin K., Cammer M., McMorris F. A., Stitt T. N., Basch R. S., Shafit-Zagardo B., (2003) The growth arrest-specific gene product Gas6 promotes the survival of human oligodendrocytes via a phosphatidylinositol 3-kinase-dependent pathway. The Journal of Neuroscience 23: 4208–4218.
48. Stenhoff J., Dahlback B., Hafizi S., (2004) Vitamin K-dependent Gas6 activates ERK kinase and stimulates growth of cardiac fibroblasts. Biochemical and Biophysical Research Communications 319: 871–878.
49. Stolt C. C., Schlierf A., Lommes P., Hillgartner S., Werner T., Kosian T., Wegner M., (2006) SoxD proteins influence multiple stages of oligodendrocyte development and modulate SoxE protein function. Developmental Cell 11: 697–709.
50. Tsiperson V., Li X., Schwartz G. J., Raine C. S., Shafit-Zagardo B., (2010) GAS6 enhances repair following cuprizone-induced demyelination. PLoS One 5: e15748.
51. van der Star B. J., Vogel D. Y., Kipp M., Puentes F., Baker D., Amor S., (2012) In vitro and in vivo models of multiple sclerosis. CNS & Neurological Disorders Drug Targets 11: 570–588.
52. Vouri M., An Q., Birt M., Pilkington G. J., Hafizi S., (2015) Small molecule inhibition of Axl receptor tyrosine kinase potently suppresses multiple malignant properties of glioma cells. Oncotarget 6: 16183–16197.
53. Weinger J. G., Brosnan C. F., Loudig O., Goldberg M. F., Macian F., Arnett H. A., Shafit-Zagardo B., (2011) Loss of the receptor tyrosine kinase Axl leads to enhanced inflammation in the CNS and delayed removal of myelin debris during experimental autoimmune encephalomyelitis. Journal of Neuroinflammation 8: 49.
54. Wolswijk G., (2002) Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord. Brain: A Journal of Neurology 125: 338–349.
55. Yanagita M., Arai H., Nakano T., Ohashi K., Mizuno K., Fukatsu A., Kita T., (2001) Gas6 induces mesangial cell proliferation via latent transcription factor STAT3. The Journal of Biological Chemistry 276: 42364–42369.
56. Zhang H., Jarjour A. A., Boyd A., Williams A., (2011) Central nervous system remyelination in culture—A tool for multiple sclerosis research. Experimental Neurology 230: 138–148.
57. Zheng M., Wei J., Tang Y., Yang C., Wei Y., Yin X., Liu Q., (2014) ApoE-deficient promotes blood-brain barrier disruption in experimental autoimmune encephalomyelitis via alteration of MMP-9. Journal of Molecular Neuroscience: MN 54: 282–290.